Company intelligence / Profile preview

Phycom

Veenendaal, Utrecht province, Netherlandsphycom.eu ↗

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

Phycom produces high-quality, food-safe microalgae at industrial scale using a sustainable, closed production system. Their products are used as alternative proteins and nutritional additives in human foods and animal feeds. The company is FSSC22000 and GMP+ certified, ensuring safety and quality. Recent investments support further scaling of their operations.

Therapeutic areas: Metabolic DisordersOther
Modalities: Microbial therapy (microalgae-based ingredients)Protein (from microalgae)Antioxidant (from microalgae)Omega‑3 fatty acids (from microalgae)
Industry: Non-Drug Biotech

Partnerships

Corbion Algae Ingredients (strategic partnership)

Beyond the preview

Go deeper on Phycom.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phycom.

Explore the full profile